FR1516777A - Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation - Google Patents

Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation

Info

Publication number
FR1516777A
FR1516777A FR71783A FR71783A FR1516777A FR 1516777 A FR1516777 A FR 1516777A FR 71783 A FR71783 A FR 71783A FR 71783 A FR71783 A FR 71783A FR 1516777 A FR1516777 A FR 1516777A
Authority
FR
France
Prior art keywords
thiazolo
pyridazine
preparation
well
thiazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR71783A
Other languages
English (en)
Inventor
Andre Lucien Pons
Max Fernand Robba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR71783A priority Critical patent/FR1516777A/fr
Application granted granted Critical
Publication of FR1516777A publication Critical patent/FR1516777A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR71783A 1966-08-02 1966-08-02 Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation Expired FR1516777A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR71783A FR1516777A (fr) 1966-08-02 1966-08-02 Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR71783A FR1516777A (fr) 1966-08-02 1966-08-02 Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation

Publications (1)

Publication Number Publication Date
FR1516777A true FR1516777A (fr) 1968-02-05

Family

ID=8614672

Family Applications (1)

Application Number Title Priority Date Filing Date
FR71783A Expired FR1516777A (fr) 1966-08-02 1966-08-02 Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation

Country Status (1)

Country Link
FR (1) FR1516777A (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050458A2 (fr) * 1980-10-14 1982-04-28 Pfizer Inc. Guanidino-2-hétéroarylthiazoles-4 et produits pharmaceutiques qui les contiennent
EP0152759A1 (fr) * 1984-01-21 1985-08-28 BASF Aktiengesellschaft Composés d'aminoisothiazole
EP0419944A2 (fr) * 1989-09-26 1991-04-03 BASF Aktiengesellschaft Amides d'acides oxazole et thiazolecarboxyliques
US5244867A (en) * 1989-09-26 1993-09-14 Basf Aktiengesellschaft Oxazole- and thiazolecarboxamides
JP2725886B2 (ja) * 1990-11-30 1998-03-11 帝人株式会社 ２―アリールチアゾール誘導体及びその医薬組成物
WO2001023375A2 (fr) * 1999-09-28 2001-04-05 Bayer Corporation Pyridines et pyridazines substituees a activite inhibitrice de l'angiogenese
EP1321463A1 (fr) * 2001-12-21 2003-06-25 Shire Biochem Inc. Dérivés de thiazole et leur utilisation dans le traitement ou la prévention d'infections par des Flavivirus
US6689883B1 (en) 1999-09-28 2004-02-10 Bayer Pharmaceuticals Corporation Substituted pyridines and pyridazines with angiogenesis inhibiting activity
WO2006032322A1 (fr) * 2004-09-20 2006-03-30 4Sc Ag NOUVEAUX INHIBITEURS HÉTÉROCYCLIQUES DU NF-κB
US7601745B2 (en) 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
US7812041B2 (en) 2004-09-20 2010-10-12 4Sc Ag Heterocyclic NF-κB inhibitors
WO2010128163A3 (fr) * 2009-05-08 2011-01-06 Pike Pharma Gmbh Inhibiteurs à petite molécule du virus de la grippe a et b et de la réplication du virus respiratoire syncytial
US7977333B2 (en) 2000-04-20 2011-07-12 Bayer Healthcare Llc Substituted pyridines and pyridazines with angiogenesis inhibiting activity

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050458A2 (fr) * 1980-10-14 1982-04-28 Pfizer Inc. Guanidino-2-hétéroarylthiazoles-4 et produits pharmaceutiques qui les contiennent
EP0050458A3 (en) * 1980-10-14 1982-09-01 Pfizer Inc. 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
EP0152759A1 (fr) * 1984-01-21 1985-08-28 BASF Aktiengesellschaft Composés d'aminoisothiazole
US4785116A (en) * 1984-01-21 1988-11-15 Basf Aktiengesellschaft Aminoisothiazole compounds
US5244867A (en) * 1989-09-26 1993-09-14 Basf Aktiengesellschaft Oxazole- and thiazolecarboxamides
EP0419944A3 (en) * 1989-09-26 1991-07-17 Basf Aktiengesellschaft Oxazole and thiazole carboxylic acid amines
EP0419944A2 (fr) * 1989-09-26 1991-04-03 BASF Aktiengesellschaft Amides d'acides oxazole et thiazolecarboxyliques
JP2725886B2 (ja) * 1990-11-30 1998-03-11 帝人株式会社 ２―アリールチアゾール誘導体及びその医薬組成物
WO2001023375A2 (fr) * 1999-09-28 2001-04-05 Bayer Corporation Pyridines et pyridazines substituees a activite inhibitrice de l'angiogenese
WO2001023375A3 (fr) * 1999-09-28 2002-05-02 Bayer Ag Pyridines et pyridazines substituees a activite inhibitrice de l'angiogenese
CZ304767B6 (cs) * 1999-09-28 2014-10-08 Bayer Corporation Substituovaný pyridin a pyridazin, farmaceutická kompozice s jeho obsahem a použití
US6689883B1 (en) 1999-09-28 2004-02-10 Bayer Pharmaceuticals Corporation Substituted pyridines and pyridazines with angiogenesis inhibiting activity
JP4919567B2 (ja) * 1999-09-28 2012-04-18 バイエル・コーポレーシヨン 脈管形成抑制活性を有する置換されたピリジン類およびピリダジン類
CN100374435C (zh) * 1999-09-28 2008-03-12 拜尔药品公司 具有血管生成抑制活性的取代的哒嗪
US7977333B2 (en) 2000-04-20 2011-07-12 Bayer Healthcare Llc Substituted pyridines and pyridazines with angiogenesis inhibiting activity
US6936629B2 (en) 2001-12-21 2005-08-30 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
EP1321463A1 (fr) * 2001-12-21 2003-06-25 Shire Biochem Inc. Dérivés de thiazole et leur utilisation dans le traitement ou la prévention d'infections par des Flavivirus
EA012607B1 (ru) * 2004-09-20 2009-10-30 4Сц Аг НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-κB
US7812041B2 (en) 2004-09-20 2010-10-12 4Sc Ag Heterocyclic NF-κB inhibitors
JP2008513386A (ja) * 2004-09-20 2008-05-01 ４エスシー アーゲー 新規な複素環式ＮＦ−κＢ阻害剤
US8106048B2 (en) 2004-09-20 2012-01-31 4Sc Ag Heterocyclic NF-κB inhibitors
WO2006032322A1 (fr) * 2004-09-20 2006-03-30 4Sc Ag NOUVEAUX INHIBITEURS HÉTÉROCYCLIQUES DU NF-κB
US7601745B2 (en) 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
WO2010128163A3 (fr) * 2009-05-08 2011-01-06 Pike Pharma Gmbh Inhibiteurs à petite molécule du virus de la grippe a et b et de la réplication du virus respiratoire syncytial

Similar Documents

Publication Publication Date Title
FR1516777A (fr) Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
BE606063A (fr) Dérivés thiadiaziniques et leur préparation.
FR1508888A (fr) Dérivés de l'imidazole et leur préparation
MC624A1 (fr) Dérivés de l'isoquinoleine et leur préparation
FR1395668A (fr) Dérivés de diméthyl xanthine et leur préparation
BE611000A (fr) Dérivés de benzazocines et leur préparation
FR1530040A (fr) Dérivés de la pipérazine et leur préparation
FR1439953A (fr) Nouveaux dérivés de l'ergolène et leur préparation
OA01253A (fr) Nouveaux dérivés phosphorés de l'idole et leur préparation.
FR1514737A (fr) Dérivés de la morpholine et leur préparation
FR1509723A (fr) Dérivés du benzo-cycloheptathiophène et leur préparation
BE597793A (fr) Nouveaux dérivés de l'azépine et leur préparation.
FR1514558A (fr) Dérivés de la 1h-2, 3 benzoxazine et leur préparation
FR1488322A (fr) Dérivés pyridiniques de l'imidazo [2, 1-b] thiazole
FR1530039A (fr) Dérivés de la théophylline et leur préparation
FR1511807A (fr) Dérivés du benzo-cycloheptathiophène et leur préparation
FR1336563A (fr) Nouveaux dérivés de dianthrone-éthylènes et leur préparation
FR1339175A (fr) Nouveaux dérivés de l'oxazine et leur préparation
FR1515549A (fr) Dérivés du delta 14-prégnène et leur préparation
FR1375300A (fr) Dérivés de benzophénone et leur préparation
FR1450417A (fr) Dérivés de thiazole et leur préparation
BE604996A (fr) Dérivés de la 1,2,3,4-tétrahydroquinazolinone et leur préparation
FR1440188A (fr) Nouveaux dérivés de l'ergolène et leur préparation
BE619567A (fr) Dérivés de la yohimbine et leur préparation
FR1388605A (fr) Dérivés de sérine et leur préparation